Evaluation of Drug and Alcohol Abuse in People Aged 15 Years and Older in Iran

  • Ahmad Ali NOORBALA Mail Department of Psychiatry, Imam Khomeini Hospital, Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Armita SALJOUGHIAN Psychosomatic Fellowship, Tehran University of Medical Sciences, Tehran, Iran
  • Seyed Abbas BAGHERI YAZDI Department of Mental Health, Ministry of Health and Medical Education of Iran, Tehran, Iran
  • Elham FAGHIHZADEH Department of Biostatistics, Paramedical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Mohammad Hadi FARAHZADI Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Koorosh KAMALI Department of Public Health, School of Public Health, Zanjan University of Medical Sciences, Zanjan, Iran
  • Soghrat FAGHIHZADEH Department of Biostatistics and Epidemiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  • Ahmad HAJEBI Research Center for Addiction and Risky Behaviors (ReCARB), Psychiatric Department, Iran University of Medical Sciences, Tehran, Iran
  • Shahin AKHONDZADEH Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Mir Taher MOUSAVI Department of Sociology, University of Welfare, Tehran, Iran
Keywords:
Drug and alcohol abuse, Smoking, Iran

Abstract

Background: Drug addiction is known as one of the health, medical and social problems of the present century. Beyond the harmful physical and mental consequences for addicts, drug abuse can cause serious social problems. The aim of this study was to evaluate drug and alcohol abuse in individuals aged 15 yr and over in Iran in 2015.

Methods: This descriptive cross-sectional study was done on individuals aged 15 yr and older who lived in urban and rural areas of Iran. Overall, 36,600 individuals were selected by systematic and cluster random sampling. The postal code was used to access the samples in 31 provinces of Iran. In each province 1200 individuals (50% men, 50% women) were evaluated. The used instrument was the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), and data were analyzed using SPSS software.

Results: The results showed 4.6% of individuals used Opium and its derivatives, 0.4% used Cannabis, 0.4% used Amphetamine stimulants, 6.1% used Sedative drugs, and 2.6% used Alcoholic beverages on a regular basis. Within the last 12 months, 3.9% of individuals used Opium and its derivatives, 0.4% used Cannabis, 0.3% used Amphetamine stimulants, 5.8% used Sedative drugs, and 1.9% used Alcoholic beverages. With the exception of Sedatives drugs men used more drugs than women and residents of rural areas used more opium and its derivatives than other groups of drugs. Based on the provincial distribution, Kerman and Qom used the highest and lowest prevalence percentage of Opium and its derivatives respectively.

Conclusion: Overall, 2340000 individuals were addicts used Opium and its derivatives in 2015, therefore, medical and health officials should take all necessary measures to deal with these serious social problems.

References

WHO (2010). Global strategy to reduce the harmful use of alcohol. Geneva: World Health Organization.

United Nations Office on Drugs and Crime (2013). World Drug Report. Vienna: United Nations Office on Drugs and Crime.

Peter N, Alicia D (2010). Extent and Influence of Recreational Drug Use on Men and Women Aged 15 Years and Older in South Africa. African Journal of Drug & Alcohol Studies, 9(1): 33-48.

Pirdehghan A, PoorRezaee M, Mirzababaee BR (2017). Epidemiology of Substance abuse among Iranian Adolescents (Yazd, 2014). Iran J Psychiatry Behav Sci., 11(4): 37-43.

UNDP annual report (2015). Prevalence of substance abuse in provinces of Iran. Center for Research, Studies and Training of the Drug Control Headquarters, Tehran-Iran.

Ziaaddini H, Ziaaddini MR (2015). The Household Survey of Drug Abuse in Kerman, Iran. Journal of Applied Sciences, 5(2): 380-385.

World Drug Report (2017). United Nations Office on Drugs and Crime. United Nations publication.

RahimiMovaghar A, Kazem M, Razaghi EM (2002). Trend of drug abuse situation in Iran. Hakim Journal, 5(3): 171-182.

Sarrami H, Ghorbani M, Minouei M (2013). Trend of 4 decades on prevalence of addiction in Iran. Quarterly Journal of Research on Addiction, 26(7): 29-52.

Razzaghi EM, Hosini M, Rahimi Movaghar A, Kazem M, Madani S (2000). Rapid Assessment of Substance Abuse in Iran. Deputy of Cultural Affairs and Prevention of the Welfare Organization, office of UN Proliferation Control Program, Tehran- Iran.

Yasami MT, Shahmohamadi D, BagheriYazdi SA, Naghavi M, Zojaji A, et al (2001). Epidemiology of Substance Abuse in Islamic Republic of Iran. Report published by Ministry of Health and Medical Education of Iran.

Narenjiha H, Rafiei H, Baghestani AR, Nouri R, Shirinbian P, Vejdani R, et al (2005). Rapid Assessment of Substance Abuse in Iran- second study. Center for Research and Education on Abuse and Substance Abuse. University of Social Welfare and Rehabilitation Sciences, office of UN Proliferation Control Program, Tehran-Iran.

Narenjiha H, Rafiei H, Baghestani AR, Nouri R, Ghafouri B, Solimaninia L, Shirinbian P. (2007). Rapid Assessment of Substance Abuse in Iran- third study. Center for Research and Education on Abuse and Substance Abuse. University of Social Welfare and Rehabilitation Sciences, office of UN Proliferation Control Program, Tehran-Iran.

RahimiMovaghar A, Sharifi V, Motavalian A, Amin Esmaeili M, Hajebi A, GoudarziRad R, Hefazi M (2012). Iran Mental Health Survey. Report published by Ministry of Health and Medical Education of Iran.

Research Institute of Humanities and Social Studies of Jihad University (2011). National Survey of Drug Use among Citizens of the Islamic Republic of Iran. Office of Drug Research of Headquarter for Drug Abuse.

Rajabpour M, Bagheri Yazdi SA, Rajabpour F (2009). Descriptive study of MOH&ME activities on prevention and treatment of substance abuse during years 1997-2007. Mashhad, Ghaf Mashhadoreza Publication.

Noorbala AA, Faghihzadeh S, Kamali K, Bagheri-Yazdi SA, Hajebi A, Mousavi MT, et al. (2017). Mental health survey of the adult population of Iran in 2015. Arch Iran Med, 20(3): 128 – 134.

Henry-Edwards S, Humeniuk RE, Ali RL, Poznyak V, Monteiro M (2003). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Guidelines for use in Primary Care, Draft Version 1.1 for Field Testing. Geneva, WHO.

WHO ASSIST Working Group (2002). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, Reliability and Feasibility. Addiction, 97: 1183-1194.

Humeniuk RE, Ali RA, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, and et al. Validation of the Alcohol Smoking and Substance Involvement Screening Test (ASSIST). Addiction, 103(6): 1039-104.

Noorbala AA, Faghihzadeh S, Kamali K, Bagheri-Yazdi SA, Hajebi A, Mousavi MT, and et al. (2017). Mental health survey of the adult population of Iran in 2015. Arch Iran Med. 20(3): 128 – 134.

Amin-Esmaeili M, Rahimi-Movagher A, Sharifi V, Hajebi A, Radgoudarzi R, Mojtabai R (2016). Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction, 111(10): 1836-1847.

Published
2020-10-01
How to Cite
1.
NOORBALA AA, SALJOUGHIAN A, BAGHERI YAZDI SA, FAGHIHZADEH E, FARAHZADI MH, KAMALI K, FAGHIHZADEH S, HAJEBI A, AKHONDZADEH S, MOUSAVI MT. Evaluation of Drug and Alcohol Abuse in People Aged 15 Years and Older in Iran. Iran J Public Health. 49(10):1940-1946.
Section
Original Article(s)